Abstract:Phosphoinositides are important signaling molecules involved in the regulation of vesicular trafficking. It has been implicated that phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2] is involved in insulin-regulated GLUT4 translocation in adipocytes. However, it remains unclear where and how PI(4,5)P2 regulates discrete steps of GLUT4 vesicle translocation in adipocytes, especially on the exocytic arm of regulation. Here, we employed optogenetic tools to acutely control the PI(4,5)P2 metabolism in living cells. By combination of TIRFM imaging, we were able to monitor the temporal-spatial-dependent PI(4,5)P2 regulation on discrete steps of GLUT4 translocation in adipocytes. We found that the plasma membrane localized PI(4,5)P2 is crucial for proper insulin signaling propagation and for insulin-stimulated GLUT4 vesicle translocation in 3T3-L1 adipocytes. Global depletion of PI(4,5)P2 on the cell surface blunted insulin-stimulated Akt phosphorylation and abolished insulin effects in promotion of the docking and fusion of GLUT4 vesicle with the plasma membrane. Furthermore, by development of a novel optogenetic module to selectively modulate PI(4,5)P2 levels on the GLUT4 vesicle docking site, we identified an important regulatory role of PI(4,5)P2 in controlling of vesicle docking process. Local depletion of PI(4,5)P2 at the vesicle docking site promoted GLUT4 vesicle undocking, diminished insulin-stimulated GLUT4 vesicle docking and fusion, but without perturbation of insulin signaling propagation in adipocytes. Our results provide strong evidence that cell surface PI(4,5)P2 plays two distinct functions on regulation of the exocytic trafficking of GLUT4 in adipocytes. PI(4,5)P2 not only regulates the proper activation of insulin signaling in general but also controls GLUT4 vesicle docking process at the vesicle-membrane contact sites.

Phosphatidylinositol 3,4-bisphosphate: Out of the shadows and into the spotlight

Phosphatidylinositol(4,5)bisphosphate: diverse functions at the plasma membrane

A Novel Integrin-activated Pathway Forms PKB/Akt- stimulatory Phosphatidylinositol 3,4-Bisphosphate via Phosphatidylinositol 3-Phosphate in Platelets

Phosphatidylinositol-3,4,5-Triphosphate and Cellular Signaling: Implications for Obesity and Diabetes

Phosphatidylinositol 3‐phosphates—at the interface between cell signalling and membrane traffic

Advances in the Researches on the Biological Activities and Inhibitors of Phosphatidylinositol 3-Kinase.

Advances in Subunits of PI3K Class I in Cancer.

Phosphatidylinositol 3-monophosphate: A novel actor in thrombopoiesis and thrombosis

Phosphoinositide 3-kinase (PI3K) classes: From cell signaling to endocytic recycling and autophagy

Drugging the Phosphoinositide 3-Kinase (PI3K) and Phosphatidylinositol 4-Kinase (PI4K) Family of Enzymes for Treatment of Cancer, Immune Disorders, and Viral/Parasitic Infections

Phosphoinositide conversion in the endolysosomal system

Beyond PI3Ks: targeting phosphoinositide kinases in disease

PI3K isoforms in cell signalling and vesicle trafficking

Phosphatidylinositol 3-Kinase: the Oncoprotein.

Dual Function of PI(4,5)P2 in Insulin-Regulated Exocytic Trafficking of GLUT4 in Adipocytes

The phosphatidylinositol 3-Kinase–AKT pathway in human cancer

The PI3K Pathway in Human Disease

PI3K Inhibitors for Cancer Therapy: What Has Been Achieved So Far?

Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics

Small Molecules Targeting Phosphoinositide 3-Kinases

Mammalian START-like phosphatidylinositol transfer proteins - Physiological perspectives and roles in cancer biology